124 related articles for article (PubMed ID: 10743944)
1. Potent antagonists of gonadotropin releasing hormone receptors derived from quinolone-6-carboxamides.
Walsh TF; Toupence RB; Young JR; Huang SX; Ujjainwalla F; DeVita RJ; Goulet MT; Wyvratt MJ; Fisher MH; Lo JL; Ren N; Yudkovitz JB; Yang YT; Cheng K; Smith RG
Bioorg Med Chem Lett; 2000 Mar; 10(5):443-7. PubMed ID: 10743944
[TBL] [Abstract][Full Text] [Related]
2. A potent, nonpeptidyl 1H-quinolone antagonist for the gonadotropin-releasing hormone receptor.
DeVita RJ; Walsh TF; Young JR; Jiang J; Ujjainwalla F; Toupence RB; Parikh M; Huang SX; Fair JA; Goulet MT; Wyvratt MJ; Lo JL; Ren N; Yudkovitz JB; Yang YT; Cheng K; Cui J; Mount G; Rohrer SP; Schaeffer JM; Rhodes L; Drisko JE; McGowan E; MacIntyre DE; Vincent S; Carlin JR; Cameron J; Smith RG
J Med Chem; 2001 Mar; 44(6):917-22. PubMed ID: 11300873
[TBL] [Abstract][Full Text] [Related]
3. Identification of neutral 4-O-alkyl quinolone nonpeptide GnRH receptor antagonists.
DeVita RJ; Parikh M; Jiang J; Fair JA; Young JR; Walsh TF; Goulet MT; Lo JL; Ren N; Yudkovitz JB; Cui J; Yang YT; Cheng K; Rohrer SP; Wyvratt MJ
Bioorg Med Chem Lett; 2004 Nov; 14(22):5599-603. PubMed ID: 15482932
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the 4-O-alkylamine substituent of non-peptide quinolone GnRH receptor antagonists.
DeVita RJ; Goulet MT; Wyvratt MJ; Fisher MH; Lo JL; Yang YT; Cheng K; Smith RG
Bioorg Med Chem Lett; 1999 Sep; 9(17):2621-4. PubMed ID: 10498221
[TBL] [Abstract][Full Text] [Related]
5. Investigations on the 4-quinolone-3-carboxylic acid motif. 3. Synthesis, structure-affinity relationships, and pharmacological characterization of 6-substituted 4-quinolone-3-carboxamides as highly selective cannabinoid-2 receptor ligands.
Pasquini S; Ligresti A; Mugnaini C; Semeraro T; Cicione L; De Rosa M; Guida F; Luongo L; De Chiaro M; Cascio MG; Bolognini D; Marini P; Pertwee R; Maione S; Di Marzo V; Corelli F
J Med Chem; 2010 Aug; 53(16):5915-28. PubMed ID: 20718492
[TBL] [Abstract][Full Text] [Related]
6. Potent nonpeptide GnRH receptor antagonists derived from substituted indole-5-carboxamides and -acetamides bearing a pyridine side-chain terminus.
Ashton WT; Sisco RM; Yang YT; Lo JL; Yudkovitz JB; Gibbons PH; Mount GR; Ren RN; Butler BS; Cheng K; Goulet MT
Bioorg Med Chem Lett; 2001 Jul; 11(13):1727-31. PubMed ID: 11425547
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of novel quinolone and quinoline-2-carboxylic acid (4-morpholin-4-yl-phenyl)amides: a late-stage diversification approach to potent 5HT1B antagonists.
Horchler CL; McCauley JP; Hall JE; Snyder DH; Craig Moore W; Hudzik TJ; Chapdelaine MJ
Bioorg Med Chem; 2007 Jan; 15(2):939-50. PubMed ID: 17126021
[TBL] [Abstract][Full Text] [Related]
8. Novel isoxazole carboxamides as growth hormone secretagogue receptor (GHS-R) antagonists.
Liu B; Liu G; Xin Z; Serby MD; Zhao H; Schaefer VG; Falls HD; Kaszubska W; Collins CA; Sham HL
Bioorg Med Chem Lett; 2004 Oct; 14(20):5223-6. PubMed ID: 15380232
[TBL] [Abstract][Full Text] [Related]
9. Benzimidazole-5-sulfonamides as novel nonpeptide luteinizing hormone releasing hormone (LHRH) antagonists: minimization of mechanism-based CYP3A4 inhibition.
Hashimoto K; Kataoka M; Tatsuta M; Yasoshima K; Yamamoto M; Yura T; Yamamoto N; Urbahns K; Gupta JB; Li Y
Chem Pharm Bull (Tokyo); 2005 Oct; 53(10):1314-7. PubMed ID: 16204990
[TBL] [Abstract][Full Text] [Related]
10. Syntheses and structure-activity relationship studies of piperidine-substituted quinolones as nonpeptide gonadotropin releasing hormone antagonists.
Jiang J; DeVita RJ; Goulet MT; Wyvratt MJ; Lo JL; Ren N; Yudkovitz JB; Cui J; Yang YT; Cheng K; Rohrer SP
Bioorg Med Chem Lett; 2004 Apr; 14(7):1795-8. PubMed ID: 15026074
[TBL] [Abstract][Full Text] [Related]
11. Identification and initial structure-activity relationships of a novel non-peptide quinolone GnRH receptor antagonist.
DeVita RJ; Hollings DD; Goulet MT; Wyvratt MJ; Fisher MH; Lo JL; Yang YT; Cheng K; Smith RG
Bioorg Med Chem Lett; 1999 Sep; 9(17):2615-20. PubMed ID: 10498220
[TBL] [Abstract][Full Text] [Related]
12. Potent pituitary-gonadal axis suppression and extremely low anaphylactoid activity of a new gonadotropin releasing hormone (GnRH) receptor antagonist "azaline B".
Campen CA; Lai MT; Kraft P; Kirchner T; Phillips A; Hahn DW; Rivier J
Biochem Pharmacol; 1995 May; 49(9):1313-21. PubMed ID: 7763313
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of 3-(2-aminoethyl) uracil derivatives as gonadotropin-releasing hormone (GnRH) receptor antagonists.
Kim SM; Lee M; Lee SY; Lee SM; Kim EJ; Kim JS; Ann J; Lee J; Lee J
Eur J Med Chem; 2018 Feb; 145():413-424. PubMed ID: 29335207
[TBL] [Abstract][Full Text] [Related]
14. Characterization of mono- and diaminopyrimidine derivatives as novel, nonpeptide gonadotropin releasing hormone (GnRH) receptor antagonists.
Luthin DR; Hong Y; Tompkins E; Anderes KL; Paderes G; Kraynov EA; Castro MA; Nared-Hood KD; Castillo R; Gregory M; Vazir H; May JM; Anderson MB
Bioorg Med Chem Lett; 2002 Dec; 12(24):3635-9. PubMed ID: 12443792
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a thieno[2,3-d]pyrimidine-2,4-dione bearing a p-methoxyureidophenyl moiety at the 6-position: a highly potent and orally bioavailable non-peptide antagonist for the human luteinizing hormone-releasing hormone receptor.
Sasaki S; Cho N; Nara Y; Harada M; Endo S; Suzuki N; Furuya S; Fujino M
J Med Chem; 2003 Jan; 46(1):113-24. PubMed ID: 12502365
[TBL] [Abstract][Full Text] [Related]
16. Identification of 1-arylmethyl-3- (2-aminoethyl)-5-aryluracil as novel gonadotropin-releasing hormone receptor antagonists.
Zhu YF; Gross TD; Guo Z; Connors PJ; Gao Y; Tucci FC; Struthers RS; Reinhart GJ; Saunders J; Chen TK; Killam Bonneville AL; Chen C
J Med Chem; 2003 May; 46(11):2023-6. PubMed ID: 12747774
[TBL] [Abstract][Full Text] [Related]
17. 2-phenyl-4-piperazinylbenzimidazoles: orally active inhibitors of the gonadotropin releasing hormone (GnRH) receptor.
Pelletier JC; Chengalvala M; Cottom J; Feingold I; Garrick L; Green D; Hauze D; Huselton C; Jetter J; Kao W; Kopf GS; Lundquist JT; Mann C; Mehlmann J; Rogers J; Shanno L; Wrobel J
Bioorg Med Chem; 2008 Jul; 16(13):6617-40. PubMed ID: 18511284
[TBL] [Abstract][Full Text] [Related]
18. 3-[(2R)-Amino-2-phenylethyl]-1-(2,6-difluorobenzyl)-5-(2-fluoro-3-methoxyphenyl)- 6-methylpyrimidin-2,4-dione (NBI 42902) as a potent and orally active antagonist of the human gonadotropin-releasing hormone receptor. Design, synthesis, and in vitro and in vivo characterization.
Tucci FC; Zhu YF; Struthers RS; Guo Z; Gross TD; Rowbottom MW; Acevedo O; Gao Y; Saunders J; Xie Q; Reinhart GJ; Liu XJ; Ling N; Bonneville AK; Chen T; Bozigian H; Chen C
J Med Chem; 2005 Feb; 48(4):1169-78. PubMed ID: 15715483
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-activity relationships of 1-arylmethyl-5-aryl-6-methyluracils as potent gonadotropin-releasing hormone receptor antagonists.
Guo Z; Zhu YF; Gross TD; Tucci FC; Gao Y; Moorjani M; Connors PJ; Rowbottom MW; Chen Y; Struthers RS; Xie Q; Saunders J; Reinhart G; Chen TK; Bonneville AL; Chen C
J Med Chem; 2004 Feb; 47(5):1259-71. PubMed ID: 14971906
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a novel, potent, and orally active nonpeptide antagonist of the human luteinizing hormone-releasing hormone (LHRH) receptor.
Cho N; Harada M; Imaeda T; Imada T; Matsumoto H; Hayase Y; Sasaki S; Furuya S; Suzuki N; Okubo S; Ogi K; Endo S; Onda H; Fujino M
J Med Chem; 1998 Oct; 41(22):4190-5. PubMed ID: 9784092
[No Abstract] [Full Text] [Related]
[Next] [New Search]
